About Renal Solutions
Renal Solutions is a company based in Warrendale (United States) founded in 2000 was acquired by Fresenius in November 2007. Renal Solutions has raised $34.5 million across 2 funding rounds from investors including Fresenius, Draper Triangle and Triathlon Medical Ventures. Renal Solutions operates in a competitive market with competitors including Invizius, VenoStent, Redsense Medical, Health Line International Corporation and Peace and Quiet Care, among others.
- Headquarter Warrendale, United States
- SectorsHealthcare
- Website renalsolutionsinc.com
- Social LinkedIn
- Acquired by Fresenius (Nov 2007)
Funding Insights of Renal Solutions
Renal Solutions has successfully raised a total of $34.5M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $16.5 million completed in March 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $34.5M
- Total Rounds 2
- Last Round Series B — $16.5M
- First Round $18M
(Jul 2003)
- Investors Count 7
All 2 funding rounds of Renal Solutions with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2005 | $16.5M | Series B | – | – | |
| Jul 2003 | $18M | Series A | – | – |
8 investors in total: 8 institutional.
Investors in Renal Solutions
Renal Solutions has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Fresenius, Draper Triangle and Triathlon Medical Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A venture fund focused on medical sector investments is managed. | – | tmvp.com | - | |
US focused early-stage VC firm investing in tech & life sciences start-ups | – | birchmerevc.com | Pittsburgh, United States | |
Late-stage investments in US tech companies are targeted. | – | bcvc.com | Cincinnati, United States | |
US focused early stage VC investments company | 1999 | drapertriangle.com | Pittsburgh, United States | |
- | – | amkeyvc.com | - | |
CID Capital is engaged in lower-middle-market buyout investments. | 1981 | cidcap.com | Carmel, United States | |
- | – | gazelle.ventures | - | |
System-critical products and services for healthcare therapies are provided. | 1912 | fresenius.com | Bad Homburg, Germany |
Investor details for Renal Solutions
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Renal Solutions
4 dated milestones of Renal Solutions across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Renal Solutions is founded.
- Funding First funding round of $18.0M.
- Funding Latest funding round, Series B, of $16.5M.
- Exit Acquired by Fresenius.
Competitors of Renal Solutions
Renal Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Invizius, VenoStent, Redsense Medical, Health Line International Corporation and Peace and Quiet Care, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| invizius.com | 2018 | Edinburgh, United Kingdom | $13.09M | 12 | Priming solutions for hemodialyzers are developed to reduce blood reactions. | |
| venostent.com | 2017 | Nashville, United States | $23.36M | – | Shape memory polymer stents are developed for vascular surgery applications. | |
| redsensemedical.com | 2006 | Halmstad, Sweden | – | – | Blood access is monitored during hemodialysis via alarm systems. | |
| hlic.net | 2004 | Salt Lake, United States | – | – | Contract Manufacturer of Dialysis products, Also sells own product lines. | |
| peaceandquietcare.co.uk | 2017 | Manchester, United Kingdom | – | – | Develops innovative renal dialysis machines with soundproof boxes. | |
| dotomedical.com | 2023 | Wrocaw, Poland | – | – | Develops medical devices to enhance hemodialysis and treat kidney disease. | |
| medcomp.net | 1978 | – | – | – | - | |
| oasproject.com | 2016 | Madrid, Spain | – | – | Develops accessory devices to support dialysis treatments. | |
| oxyless.com | 2010 | London, United Kingdom | – | – | Develops bloodlines for dialysis treatments to enhance patient care. |
Detailed competitors of Renal Solutions
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Renal Solutions
Complete news archive for Renal Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Renal Solutions
10 companies that operate in the same segment as Renal Solutions (Nephrology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Implantable battery-powered pumps for ascites removal are developed. | 2006 | Zurich, Switzerland | USD 35.5 M | – | – | |
Hemodialysis machines with touchscreen displays are provided for medical use. | 2003 | San Jose, California, United States | USD 467.37 M | USD 119.48 M | – | |
Haemodialysis systems are developed for home and clinic applications. | 2008 | Alcester, Warwickshire, United Kingdom | USD 432.84 M | USD 1.4 M | 100 | |
Provider of small molecule based drug for inflammatory kidney disease | 2004 | Stockholm, Sweden | USD 44.83 M | – | 40 | |
Therapeutics are developed for diseases with impaired kidney function. | 2014 | Lyon, Auvergne-rhone-alpes, France | USD 120.34 M | – | – | |
Therapeutics for kidney disease treatment are developed by Akebia Therapeutics. | 2007 | Cincinnati, Ohio, United States | USD 91 M | USD 236.2 M | 181 | |
Biotherapeutics for life-threatening diseases are developed, produced, and commercialized. | 2006 | Pune, Maharashtra, India | – | USD 45.26 M | 705 | |
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed. | 2002 | Hennigsdorf, Brandenburg, Germany | USD 36.14 M | – | – | |
Therapeutics for various kidney diseases are developed. | 2018 | Shanghai, China | USD 114.5 M | – | – | |
Developer of portable hemodialysis device | 2013 | Irvine, California, United States | USD 82.5 M | – | 40 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Renal Solutions
Renal Solutions was founded in 2000 and raised its 1st funding round 3 years after it was founded.
Renal Solutions is headquartered in Warrendale, United States. It is registered at Warrendale, Pennsylvania, United States.
Renal Solutions is a funded company, having raised a total of $34.5M across 2 funding rounds to date. The company's 1st funding round was a Series A of $18M, raised on Jul 2003.
Renal Solutions develops sorbents for renal replacements therapy for both acute and chronic hemodialysis. The companys Dialisorb Regenerative sorbent technology, is a dialysate purification and regeneration process. Its sorbent technology accomplishes dialysate regeneration through chemical reprocessing of the spent dialysate through the use of small amounts of dialysate made from tap water, thereby reducing the amount of wasted water used during the treatments in homes, hospitals, and other places where water is in short supply. As of November 26, 2007, Renal Solutions, Inc. operates as a subsidiary of Fresenius Medical Care.
Renal Solutions's top competitors include Invizius, VenoStent and Redsense Medical.
Renal Solutions has 8 investors. Key investors include Fresenius, Draper Triangle, Triathlon Medical Ventures, Birchmere Ventures, and Blue Chip Venture.
Yes. Renal Solutions was acquired by Fresenius in November 2007.